{"transactions":[{"id":742237,"issuer":{"id":816,"kind":"organization","name":"IDT CORP","symbol":"IDT"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock, $.01 par value per share","published_at":"2026-06-11T19:37:30.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":673,"price":55.75,"value":37519.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock that vests in full immediately."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of fully vested shares of Restricted Stock."}],"balance_after":673,"source":{"system":"sec-edgar","filing":"0001193125-26-267388","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005731/000119312526267388/ownership.xml","form_type":"4"}},{"id":751980,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-03T20:55:06.000Z","date":"2026-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":6008,"price":4.34,"value":26074.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of Restricted Stock Unit Awards granted to the Reporting Person on June 2, 2025."}],"balance_after":69992,"source":{"system":"sec-edgar","filing":"0001213900-26-064792","document":"marketforms-73188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000121390026064792/marketforms-73188.xml","form_type":"4"}},{"id":934355,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-21T21:37:27.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":158000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":158000,"derivative":{"exercise_price":5.01,"expiration_date":"2036-01-15","underlying":"Common Stock","underlying_shares":158000},"source":{"system":"sec-edgar","filing":"0001213900-26-006231","document":"marketforms-71898.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000121390026006231/marketforms-71898.xml","form_type":"4"}},{"id":934354,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-21T21:37:27.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":76000,"source":{"system":"sec-edgar","filing":"0001213900-26-006231","document":"marketforms-71898.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000121390026006231/marketforms-71898.xml","form_type":"4"}},{"id":1123109,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-04T20:10:26.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on the one year anniversary of June 2, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date."}],"balance_after":200000,"derivative":{"exercise_price":3.3,"expiration_date":"2035-06-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-25-051157","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000121390025051157/ownership.xml","form_type":"4"}},{"id":1123108,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-04T20:10:26.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of June 2, 2025."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001213900-25-051157","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000121390025051157/ownership.xml","form_type":"4"}},{"id":1166435,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-24T19:18:53.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":5485,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person received this option to purchase shares of stock in the Merger in exchange for an employee stock option granted to Mr. Conkling on June 3, 2024 to purchase 15,562 shares of Cyclo common stock at an exercise price of $1.28."}],"balance_after":5485,"derivative":{"exercise_price":3.63,"exercise_date":"2025-03-25","expiration_date":"2034-06-03","underlying":"Class B Common Stock","underlying_shares":5485},"source":{"system":"sec-edgar","filing":"0000950170-25-057934","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000095017025057934/ownership.xml","form_type":"4"}},{"id":1166434,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-24T19:18:53.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":2362,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person received this option to purchase shares of stock in the Merger in exchange for an employee stock option granted to Mr. Conkling on June 6, 2023 to purchase 6,700 shares of Cyclo common stock at an exercise price of $1.37."}],"balance_after":2362,"derivative":{"exercise_price":3.89,"exercise_date":"2025-03-25","expiration_date":"2033-06-06","underlying":"Class B Common Stock","underlying_shares":2362},"source":{"system":"sec-edgar","filing":"0000950170-25-057934","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000095017025057934/ownership.xml","form_type":"4"}},{"id":1166433,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2025-04-24T19:18:53.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":27454,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person received these shares in exchange for 77,884 shares of Cyclo Therapeutics, Inc. (\"Cyclo\") common stock in connection with the business combination between Cyclo and the Issuer (the \"Merger\") based upon an exchange ratio of 0.3525."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 174,409 shares of stock held directly, 183,094 fully vested shares of Restricted Stock and 206,952 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, June 21, 2025 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; 10,000 shares to vest on each of October 25, 2025, October 25, 2026 and October 25, 2027; and 15,000 shares to vest on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029."}],"balance_after":564455,"source":{"system":"sec-edgar","filing":"0000950170-25-057934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000095017025057934/ownership.xml","form_type":"4"}},{"id":1192332,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2025-03-25T20:39:57.000Z","date":"2025-03-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":14814,"price":1.93,"value":28591.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon the vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly, 183,094 fully vested shares of Restricted Stock and 206,952 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, June 21, 2025 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; 10,000 shares to vest on each of October 25, 2025, October 25, 2026 and October 25, 2027; and 15,000 shares to vest on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029."}],"balance_after":537001,"source":{"system":"sec-edgar","filing":"0000950170-25-044469","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000095017025044469/ownership.xml","form_type":"4"}},{"id":1237031,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-03T11:45:25.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":27654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2024 and from January 1, 2025 through March 25, 2025. The number of shares received in lieu of cash was calculated based on the closing price of $0.77 per share of common stock on February 26, 2025."}],"balance_after":77884,"source":{"system":"sec-edgar","filing":"0001437749-25-005852","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774925005852/rdgdoc.xml","form_type":"4"}},{"id":1302658,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2025-01-15T19:22:32.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":1.954,"value":117240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock that vests as follows: 15,000 shares to vest on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly, 158,925 fully vested shares of Restricted Stock and 245,935 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, March 21, 2025 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; 10,000 shares to vest on each of October 25, 2025, October 25, 2026 and October 25, 2027; and 15,000 shares to vest on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029."}],"balance_after":551815,"source":{"system":"sec-edgar","filing":"0000950170-25-005759","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000095017025005759/ownership.xml","form_type":"4"}},{"id":1322933,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2024-12-23T20:27:00.000Z","date":"2024-12-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":12807,"price":1.835,"value":23500.845,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon the vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly, 158,925 fully vested shares of Restricted Stock and 185,935 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, March 21, 2024 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; and 10,000 shares to vest on each of October 25, 2025, October 25, 2026 and October 25, 2027."}],"balance_after":491815,"source":{"system":"sec-edgar","filing":"0000950170-24-139519","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000095017024139519/ownership.xml","form_type":"4"}},{"id":1362568,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-18T14:11:09.000Z","date":"2024-11-15","kind":"grant","planned":false,"acquired":true,"shares":16660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the third quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $0.66 per share of common stock on November 14, 2024."}],"balance_after":50230,"source":{"system":"sec-edgar","filing":"0001437749-24-035589","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924035589/rdgdoc.xml","form_type":"4"}},{"id":1380081,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2024-10-29T21:15:46.000Z","date":"2024-10-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":3431,"price":1.84,"value":6313.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon the vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly, 132,749 fully vested shares of Restricted Stock and 224,918 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, December 21, 2024 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; and 10,000 shares to vest on each of October 25, 2025, October 25, 2026 and October 25, 2027."}],"balance_after":504622,"source":{"system":"sec-edgar","filing":"0000950170-24-118362","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000095017024118362/ownership.xml","form_type":"4"}},{"id":1400216,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2024-09-24T17:03:58.000Z","date":"2024-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":12696,"price":1.725,"value":21900.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon the vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly, 126,180 fully vested shares of Restricted Stock and 234,918 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, December 21, 2024 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; and 10,000 shares to vest on each of October 25, 2024, October 25, 2025, October 25, 2026 and October 25, 2027."}],"balance_after":508053,"source":{"system":"sec-edgar","filing":"0000950170-24-108970","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000095017024108970/ownership.xml","form_type":"4"}},{"id":1428254,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-20T13:49:54.000Z","date":"2024-08-16","kind":"grant","planned":false,"acquired":true,"shares":8731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the second quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $1.26 per share of common stock on August 16, 2024."}],"balance_after":33570,"source":{"system":"sec-edgar","filing":"0001437749-24-027331","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924027331/rdgdoc.xml","form_type":"4"}},{"id":1469613,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2024-06-25T18:50:08.000Z","date":"2024-06-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":13295,"price":1.455,"value":19344.225,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon the vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly, 99,893 fully vested shares of Restricted Stock and 273,901 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, September 21, 2024 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; and 10,000 shares to vest on each of October 25, 2024, October 25, 2025, October 25, 2026 and October 25, 2027."}],"balance_after":520749,"source":{"system":"sec-edgar","filing":"0000950170-24-077206","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000095017024077206/ownership.xml","form_type":"4"}},{"id":1490810,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T17:07:34.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":15562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a one year period in equal quarterly installments."}],"balance_after":15562,"derivative":{"exercise_price":1.28,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":15562},"source":{"system":"sec-edgar","filing":"0001437749-24-019341","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924019341/rdgdoc.xml","form_type":"4"}},{"id":1490809,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-05T17:07:34.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":8594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the issuer's non-employee director compensation policy. Grant reflects director compensation for the first quarter of 2024. The number of shares received in lieu of cash was calculated based on the closing price of $1.28 per share of common stock on June 3, 2024."}],"balance_after":24839,"source":{"system":"sec-edgar","filing":"0001437749-24-019341","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924019341/rdgdoc.xml","form_type":"4"}},{"id":1562000,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2024-03-25T13:40:59.000Z","date":"2024-03-21","kind":"tax_withholding","planned":false,"acquired":true,"shares":15473,"price":1.705,"value":26381.465,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon the vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly, 74,205 fully vested shares of Restricted Stock and 312,884 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, June 21, 2024 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; and 10,000 shares to vest on each of October 25, 2024, October 25, 2025, October 25, 2026 and October 25, 2027."}],"balance_after":534044,"source":{"system":"sec-edgar","filing":"0000950170-24-035671","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000095017024035671/ownership.xml","form_type":"4"}},{"id":1641648,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-15T16:41:56.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":6330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the fourth quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.58 per share of common stock on February 13, 2024."}],"balance_after":16245,"source":{"system":"sec-edgar","filing":"0001437749-24-004379","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774924004379/rdgdoc.xml","form_type":"4"}},{"id":1700202,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2023-12-26T19:23:17.000Z","date":"2023-12-21","kind":"tax_withholding","planned":false,"acquired":true,"shares":13602,"price":1.82,"value":24755.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly, 50,695 fully vested shares of Restricted Stock and 351,867 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, March 21, 2024 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; and 10,000 shares to vest on each of October 25, 2024, October 25, 2025, October 25, 2026 and October 25, 2027."}],"balance_after":549517,"source":{"system":"sec-edgar","filing":"0001209191-23-059658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000120919123059658/doc4.xml","form_type":"4"}},{"id":1727192,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-30T09:08:24.000Z","date":"2023-11-28","kind":"grant","planned":false,"acquired":true,"shares":7466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee directorcompensation policy. Grant reflects director compensation for the third quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.34per share of common stock on November 28, 2023."}],"balance_after":9915,"source":{"system":"sec-edgar","filing":"0001437749-23-033221","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923033221/rdgdoc.xml","form_type":"4"}},{"id":1754750,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2023-10-26T20:10:14.000Z","date":"2023-10-25","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":1.515,"value":60600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock that vests as follows: 10,000 shares on each of October 25, 2024, October 25, 2025, October 25, 2026 and October 25, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly, 25,314 fully vested shares of Restricted Stock and 390,850 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, December 21, 2023 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; and 10,000 shares to vest on each of October 25, 2024, October 25, 2025, October 25, 2026 and October 25, 2027."}],"balance_after":563119,"source":{"system":"sec-edgar","filing":"0001209191-23-053663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000120919123053663/doc4.xml","form_type":"4"}},{"id":1774701,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2023-09-22T13:10:45.000Z","date":"2023-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":13669,"price":2.205,"value":30140.145,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly, 25,314 fully vested shares of Restricted Stock and 350,850 shares of Restricted Stock that vest as follows: 38,983 shares to vest quarterly, December 21, 2023 through September 21, 2025; and 38,986 shares to vest on December 21, 2025."}],"balance_after":523119,"source":{"system":"sec-edgar","filing":"0001209191-23-050342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000120919123050342/doc4.xml","form_type":"4"}},{"id":1800042,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-22T16:07:54.000Z","date":"2023-08-18","kind":"grant","planned":false,"acquired":true,"shares":2449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of fully-vested shares of common stock that the Reporting Person elected to receive in lieu of cash compensation under the Issuer's non-employee director compensation policy. Grant reflects director compensation for the second quarter of 2023. The number of shares received in lieu of cash was calculated based on the closing price of $1.36 per share of common stock on August 18, 2023."}],"balance_after":2449,"source":{"system":"sec-edgar","filing":"0001437749-23-024418","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923024418/rdgdoc.xml","form_type":"4"}},{"id":1846640,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2023-06-22T17:21:56.000Z","date":"2023-06-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":15170,"price":2.15,"value":32615.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 146,955 shares of stock held directly and 389,833 shares of Restricted Stock that vest as follows: 38,983 shares to vest quarterly, September 21, 2023, through September 21, 2025; and 38,986 shares to vest on December 21, 2025."}],"balance_after":536788,"source":{"system":"sec-edgar","filing":"0001209191-23-039011","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000120919123039011/doc4.xml","form_type":"4"}},{"id":1864432,"issuer":{"id":82635,"kind":"organization","name":"Cyclo Therapeutics, Inc.","symbol":"CYTH"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2023-06-07T20:46:18.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":6700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6700,"derivative":{"exercise_price":1.37,"exercise_date":"2023-06-06","expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":6700},"source":{"system":"sec-edgar","filing":"0001437749-23-016914","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/922247/000143774923016914/rdgdoc.xml","form_type":"4"}},{"id":1940316,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2023-03-23T13:26:07.000Z","date":"2023-03-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":15625,"price":1.67,"value":26093.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 123,142 shares of stock held directly and 428,816 shares of Restricted Stock that vest as follows: 38,983 shares to vest quarterly, June 21, 2023, through September 21, 2025; and 38,986 shares to vest on December 21, 2025."}],"balance_after":551958,"source":{"system":"sec-edgar","filing":"0001209191-23-020694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000120919123020694/doc4.xml","form_type":"4"}},{"id":2076862,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2022-12-23T15:02:50.000Z","date":"2022-12-21","kind":"tax_withholding","acquired":false,"shares":56149,"price":1.76,"value":98822.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer for tax purposes upon vesting of Restricted Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 99,784 shares of stock held directly and 467,799 shares of Restricted Stock that vest as follows: 38,983 shares to vest quarterly, commencing March 21, 2023, through September 21, 2025; 38,986 shares to vest on December 21, 2025."}],"balance_after":567583,"source":{"system":"sec-edgar","filing":"0001209191-22-062549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000120919122062549/doc4.xml","form_type":"4"}},{"id":2414338,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock, par value $.01 per share","published_at":"2022-02-03T13:48:40.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":623732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock that vests as follows: 155,933 to vest on December 21, 2022; 38,983 shares to vest quarterly, commencing March 21, 2023, through September 21, 2025; and 38,986 shares to vest on December 21, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of shares of Restricted Stock that vest as follows: 155,933 to vest on December 21, 2022; 38,983 shares to vest quarterly, commencing March 21, 2023, through September 21, 2025; and 38,986 shares to vest on December 21, 2025."}],"balance_after":623732,"source":{"system":"sec-edgar","filing":"0001209191-22-006648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000120919122006648/doc4.xml","form_type":"4"}},{"id":2745354,"issuer":{"id":6620,"kind":"organization","name":"Rafael Holdings, Inc.","symbol":"RFL"},"owners":[{"id":39429,"kind":"person","name":"CONKLING WILLIAM","position":1,"cik":"0001852018","reported_name":"CONKLING WILLIAM","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-04-19T13:17:12.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":118409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest as follows: 29,602 on April 15, 2022; 2,467 monthly for thirty-five months commencing on May 15, 2022; and 2,462 on April 15, 2025."}],"balance_after":118409,"derivative":{"exercise_price":40.85,"expiration_date":"2031-04-14","underlying":"Class B Common Stock","underlying_shares":118409},"source":{"system":"sec-edgar","filing":"0001209191-21-027152","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852018/000120919121027152/doc4.xml","form_type":"4"}}]}